Dublin, Jan. 11, 2017 -- Research and Markets has announced the addition of the "Blood Glucose Device Market & Forecast (SMBG) (Test Strips, Lancet, Meter) - Worldwide Analysis" report to their offering.
It is estimated that 642 Million people will develop the disease by 2040. This is putting pressure on governments and social institutions to take necessary steps to keep the disease in check and avoid complications in order to ensure that diabetic impact is kept to a minimum. United States is the single largest market for SMBG devices market followed by Russia and United Kingdom. However, China has the highest self-monitoring of blood glucose users compared to other countries.
United States, Russia and United Kingdom together hold more than 63 percent of the total test strips market share whereas in blood glucose meter market China is the dominating country. All big players such as Roche, Bayer and Abbott Laboratories are continuously losing their market share.
Blood Glucose Device Market & Forecast (SMBG) (Test Strips, Lancet, Meter) - Worldwide Analysis analyzes the worldwide market for, blood glucose test strips market, blood glucose lancet market and blood glucose meter market.
This is the 3rd publication on the Glucose Device Market. This report studies separate comprehensive analytics for the 15 countries: United States, European Countries (United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden and Switzerland), BRIC countries (Brazil, Russia, India, China), Australia and Kuwait. Annual estimates and forecast are provided for the period of 2016 through 2020. A nine year historic analysis is also provided for these markets.
This 269 page report with 257 Figures and 12 Tables provides a complete analysis of top 15 countries of worldwide self-monitoring blood glucose (SMBG) market.
Test Strip, Lancet, Glucose Meter Market, Diabetes Population of 15 Countries covered as follows:
- Diabetes Population Scenario and Forecast in all 15 countries
- Type 1 and Type 2 Diabetes Scenario and Forecast in all 15 countries
- Self-Monitoring Blood Glucose (SMBG) Devices Users and Forecast in all 15 countries
- Self-Monitoring Blood Glucose Devices (SMBG) Market and Forecast in all 15 countries
- Blood Glucose Test Strips Market and Forecast in all 15 countries
- Blood Glucose Lancet Market and Forecast in all 15 countries
- Blood Glucose Meter Market and Forecast in all 15 countries
4 Companies Revenue (Sales) from Self-Monitoring Blood Glucose (SMBG) devices have been analyzed in this report:
- Roche Diagnostic
- LifeScan Inc.
- Bayer HealthCare
- Abbott Laboratories
Key Topics Covered:
1. Executive Summary
2. Worldwide Self-Monitoring Blood Glucose (SMBG) Users and Forecast
3. Worldwide Self-Monitoring Blood Glucose (SMBG) Market and Forecast
4. Worldwide Self-Monitoring of Blood Glucose (SMBG) Market Share and Forecast
5. United States
6. United Kingdom
7. Germany
8. Spain
9. Italy
10. Netherlands
11. Norway
12. Sweden
13. Switzerland
14. Russia
15. Brazil
16. India
17. China
18. Australia
19. Kuwait
20. SMBG Market Growth Drivers
21. SMBG Market Challenges
22. Key Players Analysis
For more information about this report visit http://www.researchandmarkets.com/research/bwfbpx/blood_glucose
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Glucose Testing, Diabetes Devices


Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Apple Turns 50: From Garage Startup to AI Crossroads
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



